Cargando…
MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
BACKGROUND: Increasing evidence suggests that aberrant methylation is involved in 5-fluorouracil (5-FU) resistance in gastric cancer (GC). Our previous work has identified that Methyl-CpG binding protein 2 (MeCP2) promotes GC progression by binding to the methylation sites of promoter regions of spe...
Autores principales: | Qin, Yannan, Ma, Xiaoping, Guo, Chen, Cai, Shuang, Ma, Hailin, Zhao, Lingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857846/ https://www.ncbi.nlm.nih.gov/pubmed/35180871 http://dx.doi.org/10.1186/s12935-022-02489-y |
Ejemplares similares
-
MeCP2 and Chromatin Compartmentalization
por: Schmidt, Annika, et al.
Publicado: (2020) -
The role of MeCP2 in learning and memory
por: Robinson, Holly A., et al.
Publicado: (2019) -
MeCP2 duplication causes hyperandrogenism by upregulating LHCGR and downregulating RORα
por: Wang, Yu-Meng, et al.
Publicado: (2021) -
miR-199a Is Upregulated in GDM Targeting the MeCP2-Trpc3 Pathway
por: Guan, Chun-Yi, et al.
Publicado: (2022) -
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
por: Collins, Bridget E, et al.
Publicado: (2022)